Faster global financial news!
Genscript Biotech's OpenCGT project has reached delivery technology cooperation agreements with multiple companies, with potential total transaction value exceeding 6 billion yuan.
Genscript ProBio's OpenCGT project, launched in 2025, aims to open the capabilities of its AiLNP platform to external companies. Currently, the project has established technical collaborations with companies such as RYZM Genomics, JingTong Life, Grandjoy Holdings Industry Platform, BioThunder AG, and Aicogen Therapeutics, covering fields including cell therapy, gene therapy, fibrosis cell programming, and in vivo immunotherapy, with a potential total transaction value exceeding RMB 6 billion. Among these, BioThunder AG has exercised its option and signed a licensing agreement, and Genscript ProBio has received an exclusive licensing fee of RMB 15 million.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
Previous: Jetron Therapeutics' MTS-128 drug licensed to Boulevard Bio in the US, has received a $20 million upfront payment, with potential milestone payments up to $1.6 billion.
|
Next: AiTEM, the AI formulation innovation platform developed by AiTEM Therapeutics, has completed its localized deployment at Hengrui Medicine and signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical.
24H Trending
-
1
Regulatory Landscape of Virtual Currencies in Mainland China and Risks Associated with Using Overseas Trading Platforms
-
2
SKR Tokenomics Analysis: The Core Driver of the Solana Mobile Ecosystem
-
3
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
4
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
5
iPhone Vulnerabilities Continue to Threaten Crypto Users, Older iOS Devices Remain at Risk
-
6
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
7
Hungary Needs Significant Deficit Cut For Euro Path, Magyar Says
-
8
Base Network: Coinbase's Layer 2 Solution and Its Ecosystem Development Status
-
9
NEMO Token: Multi-Entity Identification and Trading Status
-
10
Neo (Antcoin) In-depth Analysis: The Technical Evolution and Ecosystem Layout of "China's Ethereum"
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
